Publicaciones en las que colabora con Emad Abuassi (24)

2024

  1. Corrigendum to ‘Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score’ [American Journal of Cardiology 206 (2023) 320-329, (S000291492300766X), (10.1016/j.amjcard.2023.08.010)]

    American Journal of Cardiology

2023

  1. A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis

    Trends in Cardiovascular Medicine, Vol. 33, Núm. 5, pp. 319-326

  2. Bleeding and embolic risk in patients with atrial fibrillation and cancer

    Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 344-352

  3. Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score

    American Journal of Cardiology, Vol. 206, pp. 320-329

  4. Heart failure in older patients with atrial fibrillation: incidence and risk factors

    Revista Espanola de Cardiologia

  5. Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?

    International Journal of Cardiology, Vol. 386, pp. 59-64

  6. Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry

    Journal of the American Heart Association, Vol. 12, Núm. 15, pp. e028475

  7. IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry

    International Journal of Cardiology, Vol. 370, pp. 35-42

  8. Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection

    Life, Vol. 13, Núm. 4

2022

  1. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention

    Revista Espanola de Cardiologia, Vol. 75, Núm. 5, pp. 375-383

  2. Incidence and Predictors of Bleeding in Patients With Cancer and Atrial Fibrillation

    American Journal of Cardiology, Vol. 167, pp. 139-146

  3. Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome

    REC: CardioClinics, Vol. 57, Núm. 3, pp. 203-211

  4. Nutrition status, obesity and outcomes in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 10, pp. 826-833

  5. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  6. Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 334-342

2021

  1. Extra-adrenal paraganglioma. A cause of ventricular dysfunction?

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 141-143

  2. Paraganglioma extraadrenal: ¿causa de disfunción ventricular?

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 141-143

  3. Renin-Angiotensin System Inhibitors Prognostic Benefit in Older Patients with Atrial Fibrillation

    Journal of the American Medical Directors Association, Vol. 22, Núm. 10, pp. 2190-2195

  4. Safety of digoxin in nonagenarian patients with atrial fibrillation: lessons from the Spanish Multicenter Registry

    Journal of Geriatric Cardiology, Vol. 18, Núm. 10, pp. 809-815

2020

  1. Incidence, prognosis and predictors of heart failure after acute myocardial infarction

    REC: CardioClinics, Vol. 55, Núm. 1, pp. 8-14